目的计算放射性球囊治疗冠状动脉再狭窄时导管内核素对正常血管的剂量分布。
Objective To estimate dose distribution in normal vessels delivered by radioactive solution in the catheter for intracoronary intra-balloon brachytherapy.
目的：用置入过大直径冠状动脉内支架的方法，在正常小型猪建立模拟人类冠状动脉再狭窄的实验动物模型。
Objective:To develop an experimental animal model that accurately mimics human coronary restenosis in normal mini swine by implantation of oversized intracoronary stent.
目的：评估质粒介导下蛋白涂层金属支架局部转染血管内皮生长因子(VEGF)基因对小型猪冠状动脉再狭窄的作用。
Objective: to assess the effects of local vascular endothelial growth factor (VEGF) transfer using protein coated metallic stents on restenosis of coronary arteries in mini swine model.
目的：旨在探讨通心络胶囊防治经皮腔内冠状动脉成形术后再狭窄的临床作用及机制。
Objective: To probe probe the clinical effect and mechanism of Tongxinluo capsule in preventing and treating coronary restenosis after PTCA.
然而，支架也更容易再狭窄从而导致冠状动脉再次闭塞。
However, they are also more likely to lead to restenosis, a recurrence of artery clogging.
图示：冠状动脉血栓形成后再通。可以看到两个狭窄的通道。
This section of coronary artery demonstrates remote thrombosis with recanalization to leave on ly two small narrow channels.
随访观察6个月，采用定量冠状动脉造影的方法对比观察两组患者冠脉病变的再狭窄情况。
The condition of treated coronary artery restenosis in the two groups was compared by way of quantitative coronary angiography and a 6 month follow up study was adopted.
目的探讨冠状动脉内支架再狭窄的相关因素。
Objective To investigate the predictors of in stent restenosis in coronary artery.
目的研究切割球囊成形术（CBA）治疗高龄患者弥漫性冠状动脉（冠脉）支架内再狭窄（ISR）的安全性与疗效。
Objective To evaluate the safety and efficacy of cutting balloon angioplasty (CBA) for diffuse in-stent restenosis (ISR) in elderly patients.
目的探讨非体外循环冠状动脉旁路移植术(OPCAB)对老年冠心病患者冠状动脉支架再狭窄的治疗经验。
Objective To explore the experience about off-pump coronary artery bypass grafting (OPCAB) for the treatment of in-stent restenosis in coronary disease.
结论EGB对于动脉粥样硬化形成及经皮腔内冠状动脉介入治疗后再狭窄的防治可能具有应用前景。
CONCLUSION EGB may have some potential clinical implication in the prevention and treatment of atherosclerosis and restenosis after percutaneous transluminal coronary angioplasty.
图示：冠状动脉血栓形成后再通。可以看到两个狭窄的通道。
This section of coronary artery demonstrates remote thrombosis with recanalization to leave only two small, narrow channels.
冠状动脉搭桥手术失败的主要原因是静脉移植物的再狭窄。
Saphenous vein graft occlusion is a main reason for the failure of coronary bypass grafting.
目的：探讨在不锈钢冠状动脉支架上携带质粒基因，为心血管再狭窄基因治疗的临床应用提供试验依据。
Objective: to investigate stainless steel coronary stent-based plasmid gene delivery system and evaluate its feasibility and effectiveness to gene therapy of cardiovascular restenosis.
目的探讨多巴酚丁胺负荷超声心动图(DSE)评价经皮冠状动脉介入治疗(pci)后再狭窄的准确性和可行性。
Objective To determine the accuracy and usefulness of dobutamine stress echocardiography (DSE) in detecting restenosis after percutaneous coronary intervention (PCI).
目的：探讨临床因素对冠状动脉(冠脉)内支架置入后再狭窄的影响。
Objective: to investigate the relation between coronary stent restenosis and clinic factors.
随着对冠状动脉介入治疗后再狭窄机理研究的进展和涂层支架技术的研发成功，使药物涂层支架预防再狭窄成为可能。
With the progress of studying restenosis mechanism after coronary interventions therapy and successness of coated stent technology, it is possible to prevent from the restenosis by coated stents.
本文详细阐述了临床上常用的316L不锈钢冠状动脉支架植入后再狭窄的机理及其改性研究进展。
In this paper, the development of 316l stainless steel which is widely applied in medical field is discussed in details, including the mechanism of restenosis and the surface modification.
再狭窄是经皮冠状动脉介入治疗领域的难题。
Restenosis is a major problem in the field of percutaneous coronary intervention.
支架内再狭窄是影响经皮冠状动脉介入治疗疗效的主要原因。
In-stent restenosis is the major factor influencing the results of percutaneous coronary intervention.
目的探讨冠状动脉内支架再狭窄的机制。
Objective The purpose of this study was to assess the in stent restenotic process by intravascular ultrasound.
术后靶血管管腔再狭窄是冠状动脉介入治疗术的主要并发症，如何有效预防再狭窄已成为目前介入心脏医学界的主要课题之一。
The in-stent restenosis is one of the main complications in coronary artherosclerotic heart disease patients after PTCA and PCI.
冠心病危险因素、血管造影下冠状动脉病变特征、支架术操作技术参数是影响冠脉病变支架术后再狭窄的主要危险因子。
The risk factors of coronary artery disease, angiographic and procedural features are the main risk factors of restenosis after coronary artery stent implantation.
方法：收集冠状动脉介入治疗后造影复查再狭窄患者121例，共159处病变，进行再狭窄形式分析。
Methods: 121 Patients with 159 restenosis lesions after intracoronary interventional therapy were included in this study. Restenosis morphology of different kinds of stents were analysed.
术后6个月重复冠状动脉造影，比较两组间的晚期管腔丢失、支架再狭窄率及术后心血管不良事件发生率。
Coronary angiography was performed at the 6th month. The late lumen loss, stent restenosis and major adverse cardiac events were compared in both groups.
药物治疗是预防冠状动脉内介入治疗后再狭窄的最直接、最简便的方法。
Drug therapy is a most direct and convenient method for prevention of restenosis after percutaneous coronary intervention.
目的评估双源ct在冠状动脉支架置入术后再狭窄诊断的准确度，评价其在支架置入术后复查中的临床随访价值。
Objective to assess the accuracy and the clinical value of dual-source computed tomography (DSCT) for detecting in-stent restenosis of the coronary arteries.
目的评估双源ct在冠状动脉支架置入术后再狭窄诊断的准确度，评价其在支架置入术后复查中的临床随访价值。
Objective to assess the accuracy and the clinical value of dual-source computed tomography (DSCT) for detecting in-stent restenosis of the coronary arteries.
应用推荐